Skip to main content
. 2010 Nov 19;1(7):472–482. doi: 10.18632/oncotarget.184

Figure 2. OS in different first line treatment strategies.

Figure 2

[1] Historical comparison of overall survival for fludarabine (F), fludarabine and cyclophosphamid or mitoxantrone (FC/M) and FCR as CLL first line treatment at M. D. Anderson Cancer Center.